
|
Evolution
of Coinfection with Human Immunodeficiency Virus and Hepatitis C
Virus in Patients Treated with Highly Active Antiretroviral Therapy
[Torre D et al. CID 2001;33:1579] This is a retrospective
review from Italy concerning the impact of HAART on the course of
HCV infection in a cohort of 323 co-infected patients who were followed
for at least two years. The results showed no significant changes
in ALT or in serum levels of HCV RNA. Of the 323 participants, 15
(4.6%) died in three years and the cause of death was attributed
to cirrhosis in 5 (1.6%). Patients with ALT levels over four times
the ULN showed significant decreases in ALT, and those with normal
ALT at initiation of HAART showed a significant increase in ALT
over time. The authors conclude that HAART has little effect on
the natural history of HCV, but there may be long-term benefit or
detriment depending on the baseline ALT.
Comment: Prior studies that address this issue have shown
variable results. This is one of the larger studies, but is also
retrospective. The overall impact of HAART on HCV was minimal. Further,
the results were approximately the same with and without immune
restoration following HAART.
posted
11/19/2001

|

|